Epstein-Barr virus cytotoxic T lymphocytes
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Epstein-Barr virus cytotoxic T lymphocytes, covering 2017-08-18 to 2017-08-18. Get the full timeline:
Most recent: Clinical Trial Update: Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes [Phase 2]